UNH vs ABT
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | ABT |
|---|---|---|
| Price | $427.89 | $94.12 |
| Market cap | $388.59B | $163.94B |
| P/E ratio | 32.3 | 26.4 |
| ROE | 12.18% | 12.33% |
| Profit margin | 2.68% | 13.90% |
| Revenue growth | 2.00% | 7.80% |
| Dividend yield | 2.17% | 2.68% |
| Beta | 0.65 | 0.62 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs ABT in plain English
- UNH is the bigger company — about 2.4× the market cap of ABT.
- ABT is cheaper on earnings (P/E 26.4 vs 32.3).
- ABT earns a higher return on equity (12% vs 12%).
- ABT is growing revenue faster (8% vs 2%).
- ABT has the higher dividend yield (2.68% vs 2.17%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.